Table Graph
      published meta-analysis   sensitivity analysis   studies

standard of care in COVID-19 mild to moderate - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical deteriorationdetailed resultsELACOI (Standard of care), 2020 (REV) 1.17 [0.09; 15.46] 1.17[0.09; 15.46]ELACOI (Standard of care), 2020 (REV)10%23NAnot evaluable radiologic improvement (14-day)detailed resultsELACOI (Standard of care), 2020 (REV) 5.50 [0.25; 120.60] 5.50[0.25; 120.60]ELACOI (Standard of care), 2020 (REV)10%21NAnot evaluable radiologic improvement (7-day)detailed resultsELACOI (Standard of care), 2020 (REV) 12.57 [0.58; 270.19] 12.57[0.58; 270.19]ELACOI (Standard of care), 2020 (REV)10%21NAnot evaluable viral clearance detailed resultsELACOI (Standard of care), 2020 (REV) 0.36 [0.04; 3.26] 0.36[0.04; 3.26]ELACOI (Standard of care), 2020 (REV)10%23NAnot evaluable viral clearance by day 14detailed resultsELACOI (Standard of care), 2020 (REV) 0.36 [0.04; 3.26] 0.36[0.04; 3.26]ELACOI (Standard of care), 2020 (REV)10%23NAnot evaluable viral clearance by day 7detailed resultsELACOI (Standard of care), 2020 (REV) 1.50 [0.22; 10.30] 1.50[0.22; 10.30]ELACOI (Standard of care), 2020 (REV)10%23NAnot evaluable0.220.01.0relative treatment effectwww.metaEvidence.org2024-05-14 06:30 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 90 - treatments: 651 - roots T: 651

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons